Biacore Technology Helps Reveal New Generation of Small Molecule Therapeutics

11 December 2014

Dr Lawson, Vice President Structural Biology, explains how GE Healthcare’s Biacore™ technology has enabled researchers at UCB to complete pioneering studies into the properties of small molecules. Hear how the technology enables small molecule fragment library screening against antibody defined conformations of target proteins, revealing a whole new generation of small molecules which can address challenging protein-protein interactions.